How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease
Patients with inflammatory bowel disease (IBD) are generally considered to be more vulnerable to coronavirus disease 2019 (COVID-19). In addition, there are many concerns about the risk of severe COVID-19 infection in patients with IBD. Because the uncertainty of COVID-19 can cause confusions for patients with chronic diseases, physicians should be able to provide adequate advice for optimal treatment for patients with IBD. As the COVID-19 pandemic continues, current knowledge of COVID-19 is changing based on numerous empirical guidance and clinical data being updated daily. Based on the latest evidence, we will discuss the appropriate strategy and management of patients with IBD in the era of COVID-19..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
The Korean Journal of Gastroenterology - 77(2021), 4, Seite 160-163 |
| Sprache: |
Englisch ; Koreanisch |
|---|
| Beteiligte Personen: |
Yoo Jin Lee [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.4166/kjg.2021.403 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ055006043 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ055006043 | ||
| 003 | DE-627 | ||
| 005 | 20230308185209.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4166/kjg.2021.403 |2 doi | |
| 035 | |a (DE-627)DOAJ055006043 | ||
| 035 | |a (DE-599)DOAJfca05aa1564149bb94fdb88176b0c8a8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a kor | ||
| 100 | 0 | |a Yoo Jin Lee |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Patients with inflammatory bowel disease (IBD) are generally considered to be more vulnerable to coronavirus disease 2019 (COVID-19). In addition, there are many concerns about the risk of severe COVID-19 infection in patients with IBD. Because the uncertainty of COVID-19 can cause confusions for patients with chronic diseases, physicians should be able to provide adequate advice for optimal treatment for patients with IBD. As the COVID-19 pandemic continues, current knowledge of COVID-19 is changing based on numerous empirical guidance and clinical data being updated daily. Based on the latest evidence, we will discuss the appropriate strategy and management of patients with IBD in the era of COVID-19. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a pandemics | |
| 650 | 4 | |a inflammatory bowel diseases | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 773 | 0 | 8 | |i In |t The Korean Journal of Gastroenterology |d Jin Publishing & Printing Co., 2019 |g 77(2021), 4, Seite 160-163 |w (DE-627)DOAJ000143707 |x 22336869 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2021 |g number:4 |g pages:160-163 |
| 856 | 4 | 0 | |u https://doi.org/10.4166/kjg.2021.403 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/fca05aa1564149bb94fdb88176b0c8a8 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.kjg.or.kr/journal/view.html?uid=5693&vmd=Full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1598-9992 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2233-6869 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2021 |e 4 |h 160-163 | ||